MISTIC: A prediction tool to reveal disease-relevant deleterious missense variants
Year: 2020
Type: article
Abstract: The diffusion of next-generation sequencing technologies has revolutionized research and diagnosis in the field of rare Mendelian disorders, notably via whole-exome sequencing (WES). However, one of the main issues hampering achievement of a diagnosis via WES analyses is the extended list of variants of unknown significance (VUS), mostly composed of missense variants. Hence, improved solutions are needed to address the challenges of identifying potentially deleterious variants and ranking them in a prioritized short list. We present MISTIC (MISsense deleTeriousness predICtor), a new prediction tool based on an original combination of two complementary machine learning algorithms using a soft voting system that integrates 113 missense features, ranging from multi-ethnic minor allele frequencies and evolutionary conservation, to physiochemical and biochemical properties of amino acids. Our approach also uses training sets with a wide spectrum of variant profiles, including both high-confidence positive (deleterious) and negative (benign) variants. Compared to recent state-of-the-art prediction tools in various benchmark tests and independent evaluation scenarios, MISTIC exhibits the best and most consistent performance, notably with the highest AUC value (> 0.95). Importantly, MISTIC maintains its high performance in the specific case of discriminating deleterious variants from benign variants that are rare or population-specific. In a clinical context, MISTIC drastically reduces the list of VUS (<30%) and significantly improves the ranking of "causative" deleterious variants. Pre-computed MISTIC scores for all possible human missense variants are available at http://lbgi.fr/mistic.
Source: PLoS ONE
Authors: Kirsley Chennen(Conceptualization, Data curation, Formal analysis, Visualization, Writing – original draft), Thomas Weber(Conceptualization, Data curation, Software, Visualization), Xavière Lornage(Resources, Validation), Arnaud Kress(Resources, Software), Johann Böhm(Resources, Validation), Julie Thompson(Funding acquisition, Supervision, Writing – review & editing), Jocelyn Laporte(Funding acquisition, Resources, Supervision, Validation, Writing – review & editing), Olivier Poch(Conceptualization, Funding acquisition, Supervision, Writing – review & editing)
Language: English
Topic: Genomics and Rare Diseases
Subfield: Genetics
Domain: Life Sciences
Open Access status: gold
Estimated APC paid: $1,637
Awards: Paradigme d'inference bayesienne pour la Biologie structurale in silico, The Avon Longitudinal Study of Parents and Children (ALSPAC): A multi-generation, longitudinal resource, The Avon Longitudinal Study of Parents and Children (ALSPAC): A multi- generation, longitudinal resource focusing on life course health and well- being., G4001538951, G5923971612, Institut français de bioinformatique, ELIXIR-EXCELERATE: Fast-track ELIXIR implementation and drive early user exploitation across the life-sciences., G7210406192
OpenAlex ID: W3046471568
